Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer
Background Despite surgical and intravesical chemotherapy interventions, non-muscle invasive bladder cancer (NMIBC) poses a high risk of recurrence, which significantly impacts patient survival. Traditional clinical characteristics alone are inadequate for accurately assessing the risk of NMIBC recu...
Saved in:
| Main Authors: | Chen Zhang, Hubin Yin, Tinghao Li, Junrui Chen, Weiyang He, Ke Ren, Bo Li, Xudong Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2458211 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LncRNA SDCBP2-AS1 is a putative biomarker for postmenopausal osteoporosis and promotes osteogenic differentiation of BMSCs by regulating miR-361-3p
by: Jindong Chen, et al.
Published: (2025-07-01) -
AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses
by: Saram Abbas, et al.
Published: (2025-01-01) -
The Role of Morcellation in En Bloc Resection of Large Bladder Tumors
by: Nadav Dekel, et al.
Published: (2025-03-01) -
Prognostic value of the triglyceride—glucose index in non-muscle-invasive bladder cancer: a retrospective study
by: Yan Zhang, et al.
Published: (2024-12-01) -
Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer
by: Hasan N. Smeasm, et al.
Published: (2025-07-01)